ACEi, ARB use not tied to increased COVID-19 diagnosis, complication risk
07 Apr 2021
byRoshini Claire Anthony
Exposure to angiotensin-converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARBs) does not appear to increase the risk of being diagnosed with COVID-19 or hospitalization for COVID-19–related outcomes, according to a study.
ACEi, ARB use not tied to increased COVID-19 diagnosis, complication risk
07 Apr 2021